About bluDiagnostics
bluDiagnostics is a company based in Madison (United States) founded in 2015. bluDiagnostics has raised $1.15 million across 2 funding rounds. bluDiagnostics operates in a competitive market with competitors including Celmatix, Metabolomic Diagnostics, LIA Diagnostics, Confer Health and adyn, among others.
- Headquarter Madison, United States
- SectorsHealthcare
- Website bludiagnostics.com
- Legal Name Bludiagnostics, Inc.
- Total Equity Funding$1.15M (USD)
in 2 rounds
- Latest Funding Round$3.4M (USD), Debt – Conventional
May 2018
Funding Insights of bluDiagnostics
bluDiagnostics has successfully raised a total of $1.15M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3.4 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.15M
- Total Rounds 2
- Last Round Debt – Conventional — $3.4M
- First Round $1.15M
(Feb 2016)
All 2 funding rounds of bluDiagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2018 | $3.4M | Debt – Conventional | – | – | – |
| Feb 2016 | $1.15M | Seed | – | – | – |
Timeline of bluDiagnostics
3 dated milestones of bluDiagnostics across 3 years, from founding to its latest funding, stage changes and deals.
- Founded bluDiagnostics is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Debt – Conventional, of $3.4M.
Competitors of bluDiagnostics
bluDiagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, Metabolomic Diagnostics, LIA Diagnostics, Confer Health and adyn, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celmatix.com | 2009 | New York, United States | $24.89M | 27 | Fertility decisions are optimized using data analytics and genomics. | |
| metabolomicdiagnostics.com | 2011 | Cork, Ireland | $3.89M | – | Diagnostics and prognostics for maternal health are developed using metabolomics. | |
| liadiagnostics.com | 2015 | Philadelphia, United States | $4.22M | – | Disposable paper pregnancy test kits | |
| confer.health | 2015 | Boston, United States | $9.5M | – | Clinical-grade diagnostic tests for home use are developed. | |
| adyn.com | 2019 | Seattle, United States | $2.65M | – | Provider of DNA and hormone analysis based birth control optimization kits | |
| jabrehoo.com | 2011 | Beijing, China | $14.35M | – | Next-generation sequencing services for assisted reproduction are integrated. | |
| amolab.it | 2011 | Lecce, Italy | – | – | Portable ultrasonic devices for pregnancy monitoring are developed and manufactured. | |
| milulabs.com | 2018 | New York, United States | – | – | Exosome-based diagnostic products for health screening are offered. |
Detailed competitors of bluDiagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to bluDiagnostics
10 companies that operate in the same segment as bluDiagnostics (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 124.07 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 47 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about bluDiagnostics
bluDiagnostics was founded in 2015 and raised its 1st funding round 1 year after it was founded.
bluDiagnostics is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
bluDiagnostics is a funded company, having raised a total of $1.15M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.15M, raised on Feb 2016.
Founded in 2015 in Madison, United States, bluDiagnostics operates in the health diagnostics sector, focusing on fertility testing. A thermometer-like device is utilized to analyze saliva for estrogen and progesterone levels through disposable paper strips. Data is automatically uploaded to the cloud for viewing via a planned mobile app and integration into electronic health records. The company received the top prize at the Wisconsin Governors Business Plan Contest in 2016.
bluDiagnostics's top competitors include Celmatix, Metabolomic Diagnostics and LIA Diagnostics.
bluDiagnostics operates through Bludiagnostics, Inc..